Should You Be Worried About AstraZeneca Stock?

According to a recent poll by CNN, only one out of two Americans plan on getting a coronavirus vaccine once one is approved. And believe it or not, there are legitimate reasons to be skeptical about them. Before the pandemic, the fastest vaccine ever developed was the mumps vaccine, and that took four years. Meanwhile, the fact that we are rushing vaccines to the market in less than 12 months has many Americans worried about their quality and long-term safety profile, which ongoing clinical studies cannot yet evaluate.

Investors are arguably anxious about AstraZeneca (NASDAQ: AZN), after a series of unexplained adverse events in studies evaluating its messenger RNA (mRNA) COVID-19 vaccine. Are these safety concerns veritable or overblown?

Image Source: Getty Images.

Continue reading

Source Fool.com